Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients

Cancer Immunology Immunotherapy

Volumn 43, Issue 2, 1996, Pages 87-93

  Hanagiri, Takeshi ^a   Takenoyama, Mitsuhiro ^b   Yoshimatsu, Takashi ^a   Hirashima, Chikashi ^b   Yoshino, Ichiro ^a   Nakanishi, Kozo ^a   Nagashima, Akira ^c   Nomoto, Kikuo ^b   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

interleukin 12; interleukin 2; lung cancer; regional lymph node lymphocytes

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 12; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LYMPH NODE CELL; PRIORITY JOURNAL;

ANTIGENS, CD; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DRUG INTERACTIONS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHENOTYPE;

EID: 0029805371     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050307     Document Type: Article

References (17)

1. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK (1993) Antitumor and antimetastatic activity of Interleukin 12 against murine tumors. J Exp Med 178: 1223
2. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143: 127
3. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A (1976) Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18: 421
4. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827
5. Murata M, Yano T, Yoshino I, Togami M, Sogabe M, Yasumoto K, Sugimachi K, Kimura G, Nomoto K (1991) Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture methods. Cytotechnology 7: 75
6. Nastala CL, Edington HD, Mckinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT (1994) Recombinant IL-12 administration induces tumor regression in association with JFN-γ production. J Immunol 153: 1697
7. Nichols PH, Ramsden CW, Ward U, Trejdosiewicz LK, Ambrose NS, Primrose JN (1993) Peri-operative modulation of cellular immunity in patients with colorectal cancer. Clin Exp Immunol 94: 4
8. + lymphocytes, and NK cells. 149: 3495
9. Ratto GB, Melioli G, Zino P, Mereu C, Mirabelli S, Fantino G, Ponte M, Minuti P, Verna A, Noceti P, Tassara E, Rovida S (1995) Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer 109: 1212
10. Stern AS, Podlaski FJ, Hulmes JD, Pan Y-CE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci. USA 87: 6808
11. Takenoyama M, Yasumoto K, Harada M, Matsuzaki G, Ishida T, Sugimachi K, Nomoto K (1996) Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer. Immunobiology (in press)
12. Wingo PA, Tong T, Bolden S (1995) Cancer Statistics. CA 45: 8
13. Yaita H, Yasumoto K, Nagashima A, Sugimachi K, Nomoto K (1988) Antitumor activity of regional lymph node lymphocytes in patients with lung cancer. J Surg Oncol 38: 165
14. Yano T, Yasumoto K, Nomoto K (1989) Generation and expansion of lymphokine-activated killer cells from lymph node lymphocytes in human lung cancer. Eur J Cancer Clin Oncol 25: 201
15. Yano T, Ishida T, Yoshino I, Murata M, Yasumoto K, Kimura G, Nomoto K, Sugimachi K (1991) A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Biotherapy 3: 245
16. Yasumoto K, Ohta M, Nomoto K (1976) Cytolytic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer. Gann 67: 505
17. Yasumoto K, Miyazaki K, Nagashima A, Ishida T, Kuda T, Yano T, Sugimachi K, Nomoto K (1987) Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. Cancer Res 47: 2184